Market access in Italy: Reforms at AIFA

Mtech Access invite Pharma and Medtech market access teams to join us for this Global Whispers live webinar on Thursday 12^th October at 1.00pm (BST)/2.00pm (CEST)/8.00am (EDT).  Clare Foy (Director – Global Market Access, Mtech Access) will be speaking to Italian market access expert Prof. Fabrizio Gianfrate (Professor of Health Economics and Outcomes Research [HEOR] and Ex-Payer) about the market access landscape in Italy, particularly regarding changes at the Agenzia Italiana del Farmaco (AIFA).

Register now at: https://register.gotowebinar.com/register/3294934416894717785

This October sees the implementation of structural reforms at AIFA, the Italian Medicines Agency. The Scientific Technical Advisory Committee (CTS) and the Price and Reimbursement Committee (CPR) will be merged into a single body: the Scientific and Economic Commission (CSE). Whilst these reforms aim to slim down the reimbursement process, increase efficiencies, and reduce delays, some commentators have been critical of the changes. One key aspect is the reduction in the number of committee members, from 10 in both the CTS and CPR, to 10 in total in the CSE.

In this webinar, Italian HEOR expert and ex-payer, Prof. Fabrizio Gianfrate, will outline what these changes mean for market access in Italy and explore wider challenges that Pharmaceutical and Medical Device companies may face when launching in this market.

We will explore:

• The nature of the Italian market and the reimbursement process
• Pricing and market access considerations when launching in Italy
• What the reforms at AIFA mean for market access and managed entry agreements
• How the AIFA changes specifically impact innovative products
• Changes to early access programmes in Italy
• Impact of these changes on international pricing, particularly with the introduction of the EU Joint Clinical Assessment (JCA)

If you cannot attend the webinar but would like to know more, please register nonetheless, as all registrants will receive a recording of the webinar: https://register.gotowebinar.com/register/3294934416894717785

The webinar is free and is open to all market access, HEOR, strategic and commercial teams in Pharmaceutical, Medtech and Diagnostics companies. We also welcome attendees from healthcare systems. Some colleagues from other organisations may attend at the discretion of Mtech Access.